Viral Genetics, Inc. Hires Director of Research to Lead Product Development and Basic Research Efforts for Lab Facility at Torrey Pines Institute Molecular Studies AZUSA, Calif., Aug. 3, 2005 (PRIMEZONE) -- Viral Genetics, Inc. (OTCBB:VRAL), a drug development company developing a biological therapy for the treatment of HIV infection, today announced that it...

Viral Genetics, Inc. Provides Update on Phase 3 Trial of VGV-1 in South Africa AZUSA, Calif., July 21, 2005 (PRIMEZONE) -- Viral Genetics, Inc. (OTCBB:VRAL), a drug development company developing a biologic therapy for HIV infection, today announced that the eight-week,...